Ann Arbor, MI — 3D Biomatrix, a leader in three-dimensional cell culture products, is pleased to announce that they have collaborated with Cayman Chemical to develop and supply a new assay kit for measuring the viability of 3D spheroids. The kit, Perfecta3D® Cell Viability Kit, is one of the first viability assays optimized for 3D […]

Cambridge — Eagle Genomics, the expert provider of bioinformatics software and services across a wide range of life science and other sectors, has announced the final closing of a £1 million fundraising, as it continues to expand and develop new bioinformatics products. Eagle uses advanced computing to answer complex biological problems, from fighting cancer to […]

SUNNYVALE, California –– Labcyte Inc., the acoustic dispensing company, has been awarded $1 million to create an innovative process to detect cancer-related proteins in samples, with initial work in breast cancer detection. The unsurpassed precision and accuracy of Labcyte acoustic liquid handling enables biomarker detection by measuring multiple proteins with a MALDI mass spectrometer. Recent […]

SAN DIEGO — Organovo Holdings, Inc. (NYSE MKT: ONVO) (“Organovo”), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today provided guidance on topics to be discussed at an upcoming Retail Investor Conference on December 5, 2013. Organovo’s Chairman and Chief Executive Officer, Keith Murphy, will be presenting on Thursday, December 5, 2013 […]

WATERTOWN, Mass. — Dynasil Corporation of America (NASDAQ: DYSL) today announced that its contract research subsidiary, RMD Inc., has received four grants totaling $4.0 million under the U.S. Department of Energy’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. “RMD’s world-class research in nuclear detection continues to be on the cutting […]

Woburn, MA — Any Element, any Compound, any Mineral – Anywhere on the Planet. SciAps, Inc. (SciAps or the Company), a Boston-based instrumentation company specializing in handheld and portable analytical instruments, recently announced that it has received a $2.5 million investment led by new investor Gefinor Ventures, with follow-on participation from existing investors Rand Capital, […]

Oxford, UK. Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has co-ordinated a secondary placing of shares on behalf of certain shareholders. The majority of this transaction was the acquisition of Illumina’s 13.5% shareholding in Oxford Nanopore by other investors for £56.4 million. Oxford Nanopore announced in October […]

Redwood City, California –– GenapSys™, Inc. (GenapSys), a provider of Next Generation Sequencing (NGS) systems, today announced it has raised $37M to commercialize the GENIUS™ 110 system (Gene Electronic Nano-Integrated Ultra-Sensitive), a fully integrated DNA Sequencing system for the rapidly evolving NGS market. The Series B financing includes new investors Yuri Milner, Stanford StartX Fund, […]

FREMONT, Calif. — WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today its financial results for the third quarter ended September 30, 2013. Total revenue for the third quarter of 2013 was $390,000, up 121% from $177,000 in the third quarter of 2012. Net loss for the third quarter of 2013 was $11.0 million, compared to a […]

Atlanta, GA –– Lumense, an Atlanta-based developer of real-time quality control sensors capable of continuously measuring the contents of gases and liquids, has raised a Series B round led by the GRA Venture Fund and The Coca-Cola Company. The funds will be used to move the company’s flexible and scalable sensor platform, and its initial […]